• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性或复发性甲状腺癌的中央区翻修手术:生存率和并发症发生率分析

Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.

作者信息

Molteni Gabriele, Bonali Marco, Mattioli Francesco, Ghirelli Michael, Fermi Matteo, Ferri Gaetano, Andrea Malagoli, Presutti Livio

机构信息

Otorhinolaryngology-Head and Neck Surgery Department, University Hospital of Verona, AOUI Borgo Trento, Piazzale Aristide Stefani, 1, 37126, Verona, Italy.

Otorhinolaryngology-Head and Neck Surgery Department, University Hospital of Modena, Largo del Pozzo, 71, 41125, Modena, Italy.

出版信息

Eur Arch Otorhinolaryngol. 2019 Feb;276(2):551-557. doi: 10.1007/s00405-018-5239-2. Epub 2018 Dec 10.

DOI:10.1007/s00405-018-5239-2
PMID:30535975
Abstract

PURPOSE

Locoregional recurrence of thyroid carcinoma is relatively common and reported rate are between 5 and 20%. Cervical nodes are usually involved, especially at the central compartment. The management of recurrent thyroid carcinoma at central compartment still remains challenging because of higher incidence of complication rate. The aim of the study is to evaluate the survival and complications rate after revision surgery.

METHODS

Retrospective cohort study on a group of patients that underwent revision surgery for persistent or recurrent thyroid carcinoma from January 1, 2003 to December 31, 2017. Survival outcomes were calculated using Kaplan-Meier method. Significant variables on univariate analysis were subjected to a Cox proportional hazards regression multivariate model.

RESULTS

Fifty-two patients involved, 22 male (40%) and 30 female (60%). Mean age was 54 years old (range 24-85). Mean follow-up was 79 months, median follow-up was 85 months, with a range between 8 and 153 months. The 5-year overall survival was 90.8% while at 10 years it was 69.8%. The 5-year disease-specific survival was 93.5%, while at 10 years it dropped to 77.9%. The rate of recurrent laryngeal nerve paralysis and persistent hypocalcemia in our series were 1.3% and 5.9%, respectively. No evidence of thoracic duct, esophageal or laryngeal and tracheal injury was found in this case series. Regarding prognostic factors, univariate and multivariate analysis highlighted as statistically significant: the aggressive histological variants, the presence extranodal extension or soft-tissue metastasis.

CONCLUSION

The surgical option remains the gold standard in locoregional recurrences of thyroid carcinoma and should be performed by experienced surgeons to reduce postoperative complications.

摘要

目的

甲状腺癌局部区域复发相对常见,报道的复发率在5%至20%之间。颈部淋巴结通常受累,尤其是中央区。由于并发症发生率较高,中央区复发性甲状腺癌的治疗仍然具有挑战性。本研究的目的是评估翻修手术后的生存率和并发症发生率。

方法

对2003年1月1日至2017年12月31日期间因持续性或复发性甲状腺癌接受翻修手术的一组患者进行回顾性队列研究。使用Kaplan-Meier方法计算生存结果。单因素分析中有显著意义的变量纳入Cox比例风险回归多变量模型。

结果

共纳入52例患者,其中男性22例(40%),女性30例(60%)。平均年龄54岁(范围24 - 85岁)。平均随访79个月,中位随访85个月,范围为8至153个月。5年总生存率为90.8%,10年时为69.8%。5年疾病特异性生存率为93.5%,10年时降至77.9%。我们系列中喉返神经麻痹和持续性低钙血症的发生率分别为1.3%和5.9%。本病例系列中未发现胸导管、食管或喉及气管损伤的证据。关于预后因素,单因素和多因素分析均显示具有统计学意义的因素为:侵袭性组织学变异、存在结外扩展或软组织转移。

结论

手术仍是甲状腺癌局部区域复发的金标准,应由经验丰富的外科医生进行手术以减少术后并发症。

相似文献

1
Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.持续性或复发性甲状腺癌的中央区翻修手术:生存率和并发症发生率分析
Eur Arch Otorhinolaryngol. 2019 Feb;276(2):551-557. doi: 10.1007/s00405-018-5239-2. Epub 2018 Dec 10.
2
Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.复发性或持续性甲状腺癌中央区再次手术的并发症
Arch Otolaryngol Head Neck Surg. 2004 Oct;130(10):1214-6. doi: 10.1001/archotol.130.10.1214.
3
Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia.中央区再次手术治疗复发性/持续性分化型甲状腺癌:复发模式、发病率和术后低钙血症的预测。
Ann Surg Oncol. 2011 May;18(5):1312-8. doi: 10.1245/s10434-010-1470-9. Epub 2010 Dec 8.
4
Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.散发性甲状腺髓样癌的手术治疗策略:我们的经验
G Chir. 2012 Nov-Dec;33(11-12):395-9.
5
Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.局部复发性/持续性乳头状甲状腺癌首次再次手术后复发的危险因素
World J Surg. 2015 Aug;39(8):1943-50. doi: 10.1007/s00268-015-3052-2.
6
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.复发性/持续性甲状腺乳头状癌患者行全面中央区清扫术的长期疗效。
Thyroid. 2011 Dec;21(12):1309-16. doi: 10.1089/thy.2011.0170.
7
Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?中央区颈清扫术对于治疗甲状腺乳头状癌侧颈部淋巴结复发是否必要?
Head Neck. 2007 Oct;29(10):901-6. doi: 10.1002/hed.20606.
8
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
9
Selective lateral compartment neck dissection for thyroid cancer.选择性颈侧区淋巴结清扫术治疗甲状腺癌。
J Surg Res. 2013 Sep;184(1):193-9. doi: 10.1016/j.jss.2013.04.084. Epub 2013 May 23.
10
Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.伴有侧颈淋巴结转移的甲状腺乳头状癌复发:预测因素及手术治疗
Surgery. 2016 Mar;159(3):755-62. doi: 10.1016/j.surg.2015.08.033. Epub 2015 Oct 2.

引用本文的文献

1
Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.主动监测是一种可行且安全的策略,适用于在甲状腺切除术后发现可疑颈部淋巴结的特定甲状腺乳头状癌患者。
Arch Endocrinol Metab. 2024 May 6;68:e230146. doi: 10.20945/2359-4292-2023-0146.
2
Demographic, clinical, and surgical features of patients undergoing thyroidectomy due to thyroid lesions in Southern Iran: A cross-sectional study.伊朗南部因甲状腺病变接受甲状腺切除术患者的人口统计学、临床和手术特征:一项横断面研究。
Health Sci Rep. 2024 Apr 1;7(4):e2012. doi: 10.1002/hsr2.2012. eCollection 2024 Apr.
3

本文引用的文献

1
American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults.美国甲状腺协会关于成人术后甲状旁腺功能减退症的声明:诊断、预防和管理。
Thyroid. 2018 Jul;28(7):830-841. doi: 10.1089/thy.2017.0309. Epub 2018 Jun 29.
2
Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.淋巴结密度与甲状腺乳头状癌患者生存的关系。
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):108-114. doi: 10.1001/jamaoto.2017.2416.
3
Polydimethylsiloxane Injection Laryngoplasty for Unilateral Vocal Fold Paralysis: Long-Term Results.
Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
甲状腺乳头状癌颈淋巴结转移危险因素的相关性分析。
Diagn Pathol. 2024 Jan 13;19(1):13. doi: 10.1186/s13000-024-01440-1.
4
Ultrasound radiomics nomogram for predicting large-number cervical lymph node metastasis in papillary thyroid carcinoma.用于预测甲状腺乳头状癌大量颈部淋巴结转移的超声影像组学列线图
Front Oncol. 2023 Jun 8;13:1159114. doi: 10.3389/fonc.2023.1159114. eCollection 2023.
5
The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.再次手术治疗持续性/复发性甲状腺乳头状癌患者的结局和预后因素。
BMC Surg. 2022 Nov 2;22(1):374. doi: 10.1186/s12893-022-01819-1.
6
Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer.分化型甲状腺癌预防性中央区淋巴结清扫术
Acta Clin Croat. 2020 Jun;59(Suppl 1):87-95. doi: 10.20471/acc.2020.59.s1.11.
7
Preoperative Sonographic and Clinicopathological Predictors for Solitary Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study.甲状腺乳头状癌单侧颈部淋巴结转移的术前超声及临床病理预测因素:一项回顾性研究
Cancer Manag Res. 2020 Mar 12;12:1855-1862. doi: 10.2147/CMAR.S244406. eCollection 2020.
聚二甲基硅氧烷注射喉成形术治疗单侧声带麻痹:长期疗效
J Voice. 2017 Jul;31(4):517.e1-517.e7. doi: 10.1016/j.jvoice.2016.12.017. Epub 2017 Jan 26.
4
Complications of Bilateral Neck Dissection in Thyroid Cancer From a Single High-Volume Center.甲状腺癌双侧颈清扫术的并发症:单中心大样本量研究
JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):376-381. doi: 10.1001/jamaoto.2016.3670.
5
Surgical approach and outcomes for revision surgery of the central neck compartment.中央颈部区域翻修手术的手术入路及结果
J Craniofac Surg. 2014 Sep;25(5):1797-800. doi: 10.1097/SCS.0000000000000950.
6
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.复发性分化型甲状腺癌:基于PET评估肿瘤特征的个体化治疗(THYROPET研究):一项多中心观察性队列研究的研究方案
BMC Cancer. 2014 Jun 5;14:405. doi: 10.1186/1471-2407-14-405.
7
Evaluating the morbidity and efficacy of reoperative surgery in the central compartment for persistent/recurrent papillary thyroid carcinoma.评估中央区再次手术治疗持续性/复发性乳头状甲状腺癌的发病率及疗效。
World J Surg. 2013 Dec;37(12):2853-9. doi: 10.1007/s00268-013-2202-7.
8
Recurrent well-differentiated thyroid carcinoma.复发性分化型甲状腺癌。
Oral Oncol. 2013 Jul;49(7):689-94. doi: 10.1016/j.oraloncology.2013.03.434. Epub 2013 Apr 25.
9
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer.分化型甲状腺癌低剂量碘-131 消融治疗后的长期结果。
J Clin Endocrinol Metab. 2013 May;98(5):1819-25. doi: 10.1210/jc.2013-1197. Epub 2013 Mar 14.
10
Recurrent differentiated thyroid cancer.复发性分化型甲状腺癌。
Endocr Pract. 2012 Jul-Aug;18(4):600-3. doi: 10.4158/EP12047.CO.